KO
38
-3
PYPL
52
-2
MCHP
34
-2
SWK
50
-5
AXP
67
-2
CRM
60
-7
D
40
2
TGNA
50
-6
SE
60
-3
SYF
86
-6
TXN
43
-5
NVDA
52
-5
CAG
24
-3
CMG
66
-4
OXY
36
-2
STT
64
2
EW
32
3
PAYX
48
-6
LRCX
37
-9
EXC
54
3
KO
38
-3
PYPL
52
-2
MCHP
34
-2
SWK
50
-5
AXP
67
-2
CRM
60
-7
D
40
2
TGNA
50
-6
SE
60
-3
SYF
86
-6
TXN
43
-5
NVDA
52
-5
CAG
24
-3
CMG
66
-4
OXY
36
-2
STT
64
2
EW
32
3
PAYX
48
-6
LRCX
37
-9
EXC
54
3
Financhill
Back

Cenovus Energy Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
24

CVE
Cenovus Energy

Last Price:
15.86
Seasonality Move:
-0.66%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
43.40
Seasonality Move:
17.03%
Sell
24
Cenovus Energy (CVE) is a Sell

Is Cenovus Energy a Buy, Sell or Hold?

  • The current Cenovus Energy [CVE] share price is $15.62. The Score for CVE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • CVE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVE Stock Price Chart

What is Cenovus Energy's stock price today?

  • The Cenovus Energy share price today is $15.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVE is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CVE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 36.67 Sell
Chaikin Money Flow: -4777329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.89 - 17.05) Sell
Bollinger Bands (100): (16.54 - 19.44) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CVE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.93 Sell
20-day SMA: 16.28 Sell
50-day SMA: 16.75 Sell
200-day SMA: 18.62 Sell
8-day EMA: 15.88 Sell
20-day EMA: 16.24 Sell
50-day EMA: 16.88 Sell
200-day EMA: 18.08 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Cenovus Energy Earnings Growth & CVE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.16 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Cenovus Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):